Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| TOFA | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. |  |
| TOFA | TOFA (RMI14514;MDL14514) is an allosteric inhibitor of acetyl-CoA carboxylase-α ( ACCA ). Uses: Scientific research. Group: Signaling pathways. Alternative Names: RMI14514; MDL14514. CAS No. 54857-86-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-101068. |  |
| TOFA - CAS 54857-86-2 | A cell-permeable furoic acid compound that acts as a potent, reversible, and competitive inhibitor of acetyl-CoA carboxylase (ACC), a key enzyme involved in the fatty acid biosynthesis. Group: Fluorescence/luminescence spectroscopy. | |
| Tofacitinib | Tofacitinib is an orally available JAK3/2/1 inhibitor with IC 50 s of 1, 20, and 112 nM, respectively. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Tasocitinib; CP-690550. CAS No. 477600-75-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-40354. | |
| Tofacitinib | Tofacitinib is a novel Janus kinase 3 (JAK3) inhibitor. JAK3 is a critical cytoplasmic tyrosine kinase in the signaling pathways of multiple cytokines (interleukin (IL)-2, -7, -15 and -21) that are associated with various T cell functions. Group: Biochemicals. Alternative Names: (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)- β -oxo-1-piperidinepropane nitrile; 1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine; CP 690550; Tofacitinib. Grades: Highly Purified. CAS No. 936487-63-7. Pack Sizes: 25mg, 50mg, 100mg. US Biological Life Sciences. |  Worldwide |
| Tofacitinib-[13C3] | Tofacitinib-[13C3] is a pyrrolo[2,3-d]pyrimidine derivative, as a Janus kinase inhibitor for treatment of rheumatoid arthritis. Synonyms: 1-(Cyanoacetyl-13C3)-4R-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3R-piperidinamine. Grade: ≥90%. Molecular formula: C13[13C]3H20N6O. Mole weight: 315.35. |  |
| Tofacitinib citrate | Tofacitinib citrate. Group: Biochemicals. Alternative Names: 3-[(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile. Grades: Highly Purified. CAS No. 540737-29-9. Pack Sizes: 10mg, 25mg, 50mg, 100mg, 200mg. Molecular Formula: C16H20N6O·C6H8O7. US Biological Life Sciences. | Worldwide |
| Tofacitinib citrate | Tofacitinib citrate is an orally available JAK1/2/3 inhibitor with IC50s of 1, 20, and 112 nM, respectively. Tofacitinib citrate has antibacterial, antifungal and antiviral activities. Uses: Designed for use in research and industrial production. Additional or Alternative Names: (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile; 2-Hydroxy-1,2,3-propanetricarboxylate. Product Category: Inhibitors. CAS No. 540737-29-9. Molecular formula: C22H28N6O8. Mole weight: 504.4986. Purity: 0.96. Product ID: ACM540737299. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Tofacitinib citrate | Tofacitinib citrate is an orally available JAK1/2/3 inhibitor with IC 50 s of 1, 20, and 112 nM, respectively. Tofacitinib citrate has antibacterial, antifungal and antiviral activities. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Tasocitinib citrate; CP-690550 citrate. CAS No. 540737-29-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-40354A. | |
| Tofacitinib citrate | Tofacitinib (trade name Xeljanz, formerly tasocitinib, CP-690550) is a drug discovered and developed by Pfizer. It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection. (source: http://en.wikipedia.org/wiki/Tofacitinib). Uses: Janus kinase inhibitors. Synonyms: CP-690550; CP 690550; CP690550; Tofacitinib; tasocitinib. Grade: 98%. CAS No. 540737-29-9. Molecular formula: C22H28N6O8. Mole weight: 504.5. | |
| Tofacitinib Citrate | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopyapi standardspharmaceutical toxicology. Alternative Names: (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-?-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate (1:1), CP 690500-10, Tasocitinib citrate, Xeljanz, 3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI), CP 690550-10, Tofacitinib citrate. | |
| Tofacitinib Citrate Liposome | Tofacitinib Citrate (TOF) is a JAK3 inhibitor that achieves efficacy in treating rheumatoid arthritis by inhibiting the intracellular target Janus kinases (JAKs). This product is a pre-formulated liposome encapsulating Tofacitinib Citrate. It is only for research purposes. Group: Drug-loaded liposome. Categories: Niosomes, ethosomes, and transfersomes. |  |
| Tofacitinib-[d3] | One of the isotopic labelled form of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: 3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile-d3. Molecular formula: C16H17D3N6O. Mole weight: 315.39. | |
| Tofacitinib Impurity 5 | Tofacitinib Impurity 5. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride. CAS No. 1062580-52-2. Molecular formula: C14H22N2·2HCl. Mole weight: 291.26. Catalog: APB1062580522. | |
| Tofatinib Impurity 20 | Tofatinib Impurity 20. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1092578-44-3. Molecular formula: C27H31N5O2S. Mole weight: 489.64. Catalog: APB1092578443. | |
| Tofatinib Impurity 22 | Tofatinib Impurity 22. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1092578-45-4. Molecular formula: C20H25N5. Mole weight: 335.45. Catalog: APB1092578454. | |
| Tofatinib Impurity 30 | Tofatinib Impurity 30. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1675248-18-6. Molecular formula: C18H25N5O3. Mole weight: 359.43. Catalog: APB1675248186. | |
| Tofatinib Impurity 31 | Tofatinib Impurity 31. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1243290-37-0. Molecular formula: C15H21N5O2. Mole weight: 303.37. Catalog: APB1243290370. | |
| Tofatinib Impurity 33 | Tofatinib Impurity 33. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1527525-58-1. Molecular formula: C15H18N6O. Mole weight: 298.34. Catalog: APB1527525581. | |
| Tofatinib Impurity A | Tofatinib Impurity A. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1092578-46-5. Molecular formula: C16H20N6O. Mole weight: 312.38. Catalog: APB1092578465. | |
| Tofatinib Impurity D | Tofatinib Impurity D. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1252883-90-1. Molecular formula: C20H25N5. Mole weight: 335.45. Catalog: APB1252883901. | |
| Tofatinib Impurity Q | Tofatinib Impurity Q. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1675248-19-7. Molecular formula: C16H22N6O2. Mole weight: 330.39. Catalog: APB1675248197. | |
| Tofatinib Impurity T | Tofatinib Impurity T. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1092578-43-2. Molecular formula: C16H20N6O. Mole weight: 312.38. Catalog: APB1092578432. | |
| 2-Descyano-2-ethyl Formyl-tofacitinib | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-. CAS No. 1675248-18-6. Molecular formula: C18H25N5O3. Mole weight: 359.43. | |
| (3R,4S)-Tofacitinib | (3R,4S)-Tofacitinib is a less active enantiopure stereoisomer of the JAK3 inhibitor Tofacitinib. Synonyms: Tofacitinib Impurity A; 3-((3R,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile. Grade: >98%. CAS No. 1092578-46-5. Molecular formula: C16H20N6O. Mole weight: 312.27. | |
| (3R,4S)-Tofacitinib | (3R,4S)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC 50 of 1 nM. Uses: Scientific research. Group: Signaling pathways. CAS No. 1092578-46-5. Pack Sizes: 5 mg; 10 mg. Product ID: HY-40354D. | |
| (3S,4R)-Tofacitinib | (3S,4R)-Tofacitinib is a less active enantiopure stereoisomer of the JAK3 inhibitor Tofacitinib. Synonyms: Tofacitinib Impurity B; 3-((3S,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile. Grade: >98%. CAS No. 1092578-48-7. Molecular formula: C16H20N6O. Mole weight: 312.27. | |
| (3S,4S)-Tofacitinib | (3S,4S)-Tofacitinib is a less active enantiopure stereoisomer of the JAK3 inhibitor Tofacitinib. Synonyms: Tofacitinib Impurity C; 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile. Grade: >98%. CAS No. 1092578-47-6. Molecular formula: C16H20N6O. Mole weight: 312.27. | |
| (3S,4S)-Tofacitinib Citrate | (3S,4S)-Tofacitinib is a less active enantiopure stereoisomer of the JAK3 inhibitor Tofacitinib. Synonyms: 2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile; 3-((3S,4S)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate. CAS No. 2174011-55-1. Molecular formula: C22H28N6O8. Mole weight: 504.50. | |
| CP 690550 Citrate (Potent JAK Inhibitor, Tofacitinib citrate) ((3R,4R)-4-Methyl-3-(methyl-7H-pyrro lo[2,3-d]pyrimidin-4-ylamino)-b-oxo-1-piperidinepro panenitrile citrate) | Potent JAK inhibitor (IC50 values are 1, 20, and 112nm for JAK3, JAK2 and JAK1 respectively). Orally active immunosuppressant; exhibits efficacy in rodent rheumatoid arthritis models. Group: Biochemicals. Grades: Highly Purified. CAS No. 540737-29-9. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| CP-690550 Citrate (Tofacitinib Citrate) | CP-690550 is a pyrrolo[2,3-d]pyrimidine derivative, as Janus kinase inhibitor for treatment of rheumatoid arthritis. Group: Biochemicals. Alternative Names: (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)- β -oxo-1-piperidinepropane nitrile; 2-Hydroxy-1,2,3-propanetricarboxylate; (3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-Hydroxy-1,2,3-propanetricarboxylate; CP 690500-10; CP 690550-10; Tofacitinib Citrate. Grades: Highly Purified. CAS No. 540737-29-9. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Dihydro Tofacitinib Citrate | An impurity of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: Tofacitinib Impurity; 5,6-Dihydro CP-690550 citrate; 5,6-Dihydro Tofacitinib citrate. Molecular formula: C22H30N6O8. Mole weight: 506.51. | |
| 1,3-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)propane-1,3-dione | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: Tofacitinib Impurity 27. CAS No. 2504210-41-5. Molecular formula: C29H38N10O2. Mole weight: 558.69. | |
| 1-Benzyl-4-methyl-3-(methylamino)piperidine Dihydrochloride | A dihydrochloride salt form of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine; dihydrochloride; 1-benzyl-N,4-dimethylpiperidin-3-amine; dihydrochloride. Grade: 99 %. CAS No. 1228879-37-5. Molecular formula: C14H24Cl2N2. Mole weight: 291.26. | |
| 1-Benzyl-4-methyl-3-piperidinamine | 1-Benzyl-4-methyl-3-piperidinamine is an intermediate of Tofacitinib (T528000); an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases. Group: Biochemicals. Grades: Highly Purified. CAS No. 1039738-27-6. Pack Sizes: 250mg, 1g. Molecular Formula: C13H20N2, Molecular Weight: 204.31. US Biological Life Sciences. | Worldwide |
| 1-Benzyl-N,4-dimethyl-3-piperidinamine | 1-Benzyl-N,4-dimethyl-3-piperidinamine is an impurity of Tofacitinib, which is a Janus kinase inhibitor used in the treatment of rheumatoid arthritis. Synonyms: 3-Piperidinamine, N,4-dimethyl-1-(phenylmethyl)-; N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine; (1-Benzyl-4-methylpiperidin-3-yl)methylamine; 1-Benzyl-N-methyl-4-methylpiperidin-3-amine; N,?4-Dimethyl-1-benzyl?-3-piperidinamine; Tofacitinib Impurity F; Tofacitinib Impurity 102. Grade: ≥95%. CAS No. 384338-23-2. Molecular formula: C14H22N2. Mole weight: 218.34. | |
| 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: 2,6-Dichloro-7-deazapurine; Tofacitinib Impurity 08; 1H-Pyrrolo[2,3-d]pyrimidine, 2,4-dichloro-. CAS No. 90213-66-4. Molecular formula: C6H3Cl2N3. Mole weight: 188.01. | |
| 2-chloro-N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: N-((3R,4R)-4-methyl-piperidin-3-yl)-N-methyl-2-chloro-7H-pyrrolo[2,3-D]pyrimidine-4-amine; Tofacitinib Impurity 31. CAS No. 1616760-97-4. Molecular formula: C13H18ClN5. Mole weight: 279.77. | |
| 2-cyano-N-methyl-N-((3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)acetamide | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: Tofacitinib impurity T; Tofacitinib Impurity 23; Acetamide, 2-cyano-N-methyl-N-[(3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-3-piperidinyl]-. Grade: 95% HPLC. CAS No. 1092578-43-2. Molecular formula: C16H20N6O. Mole weight: 312.37. | |
| 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: N-Methyl-N-(3R,4R)-1-cyanoacetyl-4-methylpiperidin-3-yl-2-chloro-7-deazapurine-6-amine; Tofacitinib Impurity 21. Grade: 98%. CAS No. 1616761-00-2. Molecular formula: C16H19ClN6O. Mole weight: 346.81. | |
| 3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl) amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: Tofacitinib Impurity 37. Grade: 98% HPLC. CAS No. 2504210-48-2. Molecular formula: C22H23N9O. Mole weight: 429.49. | |
| 3-((3R,4R)-4-methyl-3-(methyl(6-oxo-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: 1-Piperidinepropanenitrile, 3-[(6,7-dihydro-6-oxo-5H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-; Tofacitinib Impurity 38. CAS No. 1640971-51-2. Molecular formula: C16H20N6O2. Mole weight: 328.37. | |
| 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: Tofacitinib Impurity 20. Grade: 98%. CAS No. 2374700-40-8. Molecular formula: C16H20N6O. Mole weight: 312.38. | |
| 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanamide; Tofacitinib Citrate Impurity 05; Tofacitinib Impurity 25. CAS No. 1675248-19-7. Molecular formula: C16H22N6O2. Mole weight: 330.38. | |
| 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoic Acid | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: Tofacitinib Impurity 26; Tofacitinib impurity K. CAS No. 2328165-36-0. Molecular formula: C16H21N5O3. Mole weight: 331.38. | |
| 3-((3R,4R)-4-methyl-3-(methyl(7-tosyl-7H-pyrrolo[2,3-d] pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: Tofacitinib Impurity 12. CAS No. 2259288-22-5. Molecular formula: C23H26N6O3S. Mole weight: 466.56. | |
| 3-((3R,4R)-4-methyl-3-(methylamino)piperidin-1-yl)-3-oxopropanenitrile hydrochloride | An impurity of Tofacitinib, a Janus kinase inhibitor that could be used against rheumatoid arthritis. CAS No. 1640971-87-4. Molecular formula: C10H18ClN3O. Mole weight: 231.72. | |
| (3R,4R)-1-Benzyl-3-(methylamino)-4-methylpiperidine Dihydrochloride | (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride is an impurity of Tofacitinib, a medication used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Synonyms: (3R,4R)-N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine; dihydrochloride; (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine; dihydrochloride. CAS No. 1062580-52-2. Molecular formula: C14H24Cl2N2. Mole weight: 291.26. | |
| (3R,4R)-4-Methyl-3-(methylamino)-β-oxo-1-piperidinepropanenitrile | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: 2-cyano-N-methyl-N-((3R,4R)-4-methyl piperidin-3-yl) Acetamide; Tofacitinib Impurity 05. CAS No. 1629858-78-1. Molecular formula: C10H17N3O. Mole weight: 195.26. | |
| (3R,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine | (3R,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine is an impurity of Tofacitinib, a medication used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. CAS No. 1638499-31-6. Molecular formula: C14H22N2. Mole weight: 218.34. | |
| (3S,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine | (3S,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine is an impurity of Tofacitinib, a medication used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Synonyms: (3S,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine. CAS No. 1638499-33-8. Molecular formula: C14H22N2. Mole weight: 218.34. | |
| (3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: Tofacitinib Impurity DT. CAS No. 1354621-59-2. Molecular formula: C14H22N2. Mole weight: 218.34. | |
| (3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride | (3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride is an impurity of Tofacitinib, a medication used to treat rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. Synonyms: Tofacitinib impurity G; Tofacitinib Impurity 02; cis-1-Benzyl-3-(methylamino)-4-methylpiperidine dihydrochloride. CAS No. 1354486-07-9. Molecular formula: C14H24Cl2N2. Mole weight: 291.3. | |
| 4'-Chloro-4,7'-bi-7H-pyrrolo[2,3-d]pyrimidine | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: 4-chloro-7-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-7H-pyrrolo[2,3-d]pyrimidine; Tofacitinib Impurity 28. CAS No. 134965-85-8. Molecular formula: C12H7ClN6. Mole weight: 270.68. | |
| 4-chloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: 5H-Pyrrolo[2,3-d]pyrimidine, 4-chloro-6,7-dihydro-; Tofacitinib Impurity 07. Grade: 97%. CAS No. 16372-08-0. Molecular formula: C6H6ClN3. Mole weight: 155.58. | |
| 6-Chloro-7-deazapurine | One of the impurities of Tofacitinib, which is a Janus kinase inhibitor and could be used against rheumatoid arthritis. Synonyms: 4-Chloro-1H-pyrrolo[2,3-d]pyrimidine; 4-Chloropyrrolo[2,3-d]pyrimidine; NSC 64952. Grade: ≥98% by HPLC. CAS No. 3680-69-1. Molecular formula: C6H4ClN3. Mole weight: 153.57. | |
| α-Tocopherol Acetate. | α-Tocopherol acetate is the most bioactive of the naturally occurring forms of Vitamin E. Richest sources are green vegetables, grains, and oils, particularly palm, safflower and sunflower oils. Group: Biochemicals. Alternative Names: (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol 6-Acetate; Ephynal Acetate; (+)-α-Tocopherol Acetate; (+)-α-Tocopheryl Acetate; (2R,4'R,8'R)-α-Tocopherol Acetate; (2R,4'R,8'R)-α-Tocopheryl Acetate; (R,R,R)-α-Tocopheryl Acetate; 2,5,7,8-Tetramethyl-2-(4,8,12-trimethyltridecyl)-6-chromanol Acetate; Alfacol; Copherol 12250; Ecofrol; Econ; Tofaxin; Tokoferol Acetate. Grades: Highly Purified. CAS No. 58-95-7. Pack Sizes: 1g. US Biological Life Sciences. | Worldwide |
| cis-1-Benzyl-N-methyl-4-methylpiperidin-3-amine | cis-1-Benzyl-N-methyl-4-methylpiperidin-3-amine is an impurity of Tofacitinib, which is a Janus kinase inhibitor used in the treatment of rheumatoid arthritis. Synonyms: 3-Piperidinamine, N,4-dimethyl-1-(phenylmethyl)-, (3R,4R)-rel-; rel-(3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine; (3R*,4R*)-1-Benzyl-N,4-dimethylpiperidin-3-amine. Grade: ≥95%. CAS No. 477600-69-4. Molecular formula: C14H22N2. Mole weight: 218.34. | |
| CP-690550A | This active molecular is a novel Janus Kinase 3 (JAK3) inhibitor. CP-690550A is an immunosuppressant for the treatment of rheumatoid arthritis, psoriasis, transplant rejection and other immune-mediated disorders. Uses: Immune-mediated disorders. Synonyms: CP-690550A; CP-690,550A; CP 690550A; CP690550A; Tofacitinib metabolite M2; UNII-Q7ZOK859UK; Tofacitinib metabolite M2; Q7ZOK859UK; CHEMBL1630791; 2-hydroxy-1-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]ethanone. Grade: 98%. CAS No. 1243290-37-0. Molecular formula: C15H21N5O2. Mole weight: 303.37. | |
| CP 690,550-d3 | CP 690,550-d3 is used as an internal standard for the quantification of CP 690,550 by GC- or LC-MS. CP 690,550 (Tofacitinib citrate) is a potent, orally available and cell-permeable inhibitor of all JAK isoforms (IC50s = 6.1, 12, and 8 nM for JAK1, JAK2, and JAK3, respectively). Synonyms: Tofacitinib citrate-d3. Grade: ≥99% atom D. Molecular formula: C16H17D3N6O·C6H8O7. Mole weight: 507.51. | |
| Notoginseng triterpenes | Notoginsenoside Fe is a natural compound isolated from the roots of Panax notoginseng. Synonyms: Sanqi tofal Saponins; Notoginsenoside Fe. Grade: >98%. CAS No. 88105-29-7. Molecular formula: C47H80O17. Mole weight: 917.13. | |
| Tall Oil Fatty Acid | Tall Oil Fatty Acid comes from Tall Oil, which is derived from the resinous part of pine trees. It is a byproduct of the kraft process, which is a method used to make paper from wood pulp. Part of it's appeal is that it's renewable and biodegradable, making it a more eco-friendly option compared to petroleum-based fatty acids. Uses: Adhesives, Alkyd Resins, Detergents, Coatings, Fuel Additives, Lubricants, Metalworking Fluids, Paints. Alternative Names: Tall Oil Acid, TOFA. Grades: Tech. CAS: 61790-12-3. Pack Sizes: 55 Gallon Drum. |  USA |
Our database is helping our users find suppliers everyday.
